Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology’s ability to automate complex workflows and enhance productivity is seen as a game-changer for the next generation of innovation.
Perhaps the most promising AI application is its potential to revolutionize medicine by accelerating the drug discovery process to deliver more effective therapies. Several biotechnology companies are embracing these cutting-edge capabilities to unlock new growth opportunities.
This post originally appeared at The Motley Fool.